市场调查报告书
商品编码
1411274
血液培养测试市场规模-按产品(仪器、消耗品)、方法(传统、自动化)、技术(培养、分子、蛋白质组)、应用(细菌、真菌感染)、最终用途(诊断中心、医院)和预测2024-2032Blood Culture Tests Market Size-By Product (Instrument, Consumable), Method (Conventional, Automated), Technology (Culture, Molecular, Proteomic), Application (Bacterial, Fungal Infections), End-use (Diagnostic Center, Hospital), & Forecast 2024-2032 |
预计从 2024 年到 2032 年,血液培养测试市场规模将以 7.9% 的CAGR扩大。全球范围内血液感染和脓毒症发病率的不断增加凸显了对准确、快速诊断工具的迫切需求。血液培养系统技术的不断进步促进了病原体的更快检测和识别,这导致了对此类测试的更高需求。例如,2023 年6 月,印度诊断公司Mylab Discovery Solutions 推出了PathoCatch 镰状细胞快速检测,这是一种针对镰状细胞贫血的条状护理点检测,透过直接提供快速、准确的结果,彻底改变了SCA 诊断和管理在患者所在位置。
自动化系统的日益普及正在推动人们不断努力提高血液培养测试的敏感度和特异性。对病人安全的日益重视,提高了医疗保健专业人员对早期、准确诊断血流感染重要性的认识。将分子诊断整合到血液培养检测方法中也将补充产业的成长。
血液培养测试市场分为产品、方法、技术、应用、最终用途和区域。
根据产品类型,由于对先进血液培养系统的需求不断增加,2024年至2032年仪器领域的产业价值预计将以8.1%的CAGR成长。持续的技术进步,例如分子诊断的自动化和集成,也将有助于提高这些仪器的功效,推动产品的采用。
由于人们对高效、高通量诊断解决方案的日益青睐,自动化方法领域的血液培养测试市场份额预计到 2032 年CAGR将达到 8%。自动化血液培养系统可提供快速、精确的病原体检测,进而缩短週转时间。自动化方法也提高了血液培养测试的整体效率,推动了该细分市场的成长。
从区域来看,亚太地区血液培养测试市场预计在 2024 年至 2032 年间将以 8.5% 的CAGR扩张。这种增长可归因于传染病发病率的上升、人们对早期准确诊断重要性的认识不断提高以及医疗保健水准的提高基础设施改善。对有效感染控制措施的日益重视和诊断程序的持续技术进步也将推动区域市场的扩张。
Blood culture tests market size is projected to expand at 7.9% CAGR from 2024 to 2032. The increasing incidences of bloodstream infections and sepsis across the globe is emphasizing the critical need for accurate and rapid diagnostic tools. The rising technological advancements in blood culture systems for promoting quicker detection and identification of pathogens is contributing to the higher demand for such tests. For instance, in June 2023, Mylab Discovery Solutions, an Indian diagnostic company, introduced PathoCatch Sickle Cell Rapid Test, a strip-based point-of-care test for Sickle Cell Anemia to revolutionize SCA diagnosis and management by providing fast and accurate results directly at the patient's location.
The growing adoption of automated systems is driving continuous efforts to enhance the sensitivity and specificity of blood culture tests. The growing emphasis on patient safety is increasing the awareness among healthcare professionals about the importance of early and precise diagnosis of bloodstream infections. The integration of molecular diagnostics into blood culture testing methodologies will also complement the industry growth.
The blood culture tests market is categorized into product, method, technology, application, end-use, and region.
Based on product type, the industry value from the instruments segment is projected to rise at 8.1% CAGR from 2024 to 2032, owing to the increasing demand for advanced blood culture systems. The ongoing technological advancements, such as automation and integration of molecular diagnostics, will also contribute to the efficacy of these instruments, driving the product adoption.
Blood culture tests market share from the automated method segment is estimated to witness 8% CAGR through 2032, due to the growing preference for efficient and high-throughput diagnostic solutions. Automated blood culture systems offer rapid and precise pathogen detection in reducing turnaround times. The automation method also enhances the overall efficiency of blood culture testing, pushing the segment growth ahead.
Regionally, the Asia Pacific blood culture tests market is projected to expand at 8.5% CAGR between 2024 and 2032. The growth can be attributed to the rising incidence of infectious diseases, increased awareness about the importance of early and accurate diagnostics, and the higher healthcare infrastructure improvements. The growing emphasis on effective infection control measures and continuous technological advancements in diagnostic procedures will also fuel the regional market expansion.